• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

CRISPR Therapeutics Stock Shows It Has Good Genes

These shares have some bullish charts.
By BRUCE KAMICH
Aug 18, 2020 | 11:41 AM EDT
Stocks quotes in this article: CRSP

CRISPR Therapeutics AG (CRSP) is a gene editing company focused on developing transformative gene-based medicines for serious diseases. That sounds amazing but it is also a stock with some bullish charts. Let's check them out. 

 
In the daily bar chart of CRSP, below, we can see that prices peaked in December and declined into a mid-March low with the movement of the broader market. It did not take long for CRSP to recoup its losses and rally to new highs. Prices are above the rising 50-day moving average line and the rising 200-day moving average line. We can see a bullish golden cross of these two averages back at the end of May/beginning of June.
 
The On-Balance-Volume (OBV) line shows a decline into a March low followed by a recovery to early July. Prices have been trading sideways since early July and the OBV line has moved sideways to lower telling us that there has been some profit-taking as prices have corrected their gains from March.
 
The Moving Average Convergence Divergence (MACD) oscillator has corrected lower since early July but the two moving averages that comprise this indicator have begun to narrow ahead of a potential new buy signal. 
 
 
 
In the weekly bar chart of CRSP, below, we can see a large sideways consolidation pattern between $25 and $75 going back to early 2018. This consolidation pattern can support a major rally. If we take the height of the pattern ($50) and add it to the breakout at $75 we get a potential target of $125. Prices are above the rising 40-week moving average line.
 
The weekly OBV line has been strong and rising since late 2018. The weekly MACD oscillator is still bullish but showing some narrowing, which implies some tapering off of the strength of the trend.
 
 
 
In this Point and Figure chart of CRSP, below, we used daily price data. Prices have formed a triangle-like pattern and look ready for an upside breakout. The software is projecting a target of $101 at this time. 
 
 
 
Bottom-line strategy: Aggressive traders could approach the long side of CRSP at current levels risking a close below $84 for now. The $101 area is our first upside price target with the $125 area then next objective derived from the height of the consolidation on the weekly chart.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Biotechnology

More from Stocks

The Market's 'Generals' Are Now in the Crosshairs

James "Rev Shark" DePorre
May 18, 2022 4:42 PM EDT

We've reached the next phase of the bear market, as big names get hit.

These Three Small-Cap Stocks Boast Big Dividends

Bob Ciura
May 18, 2022 3:00 PM EDT

Look beyond the mega-cap names for income investing to the more inclusive -- and often smaller -- Dividend Champions.

Can Nvidia Make a Rebound Rally Ahead of Earnings?

Bruce Kamich
May 18, 2022 2:32 PM EDT

Here's what I'd look for NVDA to do in the days ahead.

After Cisco Reports, Will There Be a Tradable Rally?

Bruce Kamich
May 18, 2022 12:04 PM EDT

Let's see how the charts look before earnings Wednesday night.

ServiceNow Picks Up a New Bull on Their Shares

Bruce Kamich
May 18, 2022 11:20 AM EDT

Here's what aggressive traders could do now.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • 03:07 PM EDT PAUL PRICE

    Why Is Walmart Down Big Today?

    Besides its poor earnings report Walmart was way...
  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login